Advanced search

231 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	04-23	PU
Philips : Report of the Remuneration Committee 2023	03-21	PU
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen's Association	01-10	AQ
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association	01-09	BU
Results of Philips’ 2023 Annual General Meeting of Shareholders	09/05/23	GL
Philips convenes the Annual General Meeting of Shareholders 2023	27/03/23	AQ
Philips : Binding list of nominees AGM 2023	24/03/23	PU
Philips convenes the Annual General Meeting of Shareholders 2023	24/03/23	GL
Philips convenes the Annual General Meeting of Shareholders 2023	24/03/23	AQ
BIOMARIN PHARMACEUTICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)	31/05/22	AQ
ALNYLAM PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23/05/22	AQ
Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call	10/05/22
Transcript : Bioniz Therapeutics, Inc., Equillium, Inc. - M&A Call	16/02/22
Equillium : Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates - Form 8-K	16/02/22	PU
Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates	16/02/22	BU
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of the Alnylam Pharmaceuticals, Inc. Securities Litigation	17/12/21	PR
PLIANT THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	02/07/21	AQ
BIOMARIN PHARMACEUTICAL INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	01/06/21	AQ
New Center for Higher Ambition Leadership CEO Jeannie Diefenderfer Shares Bold Vision to Increase Reach and Impact of the Nonprofit	01/06/21	PR
Transcript : BioMarin Pharmaceutical Inc. - Shareholder/Analyst Call	25/05/21
ALNYLAM PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	21/05/21	AQ
Transcript : Alnylam Pharmaceuticals, Inc. - Shareholder/Analyst Call	18/05/21
Pliant Therapeutics : Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results	16/03/21	AQ
PLIANT THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	13/01/21	AQ
Pliant Therapeutics : Announces Appointment of David Pyott to Board of Directors	12/01/21	AQ
Pliant Therapeutics, Inc. Announces Appointment of David Pyott to Board of Directors	12/01/21	CI
Easterseals Disability Film Challenge: Home Edition Winners Announced at a Star-Studded Awards Ceremony	14/08/20	BU
BIOMARIN PHARMACEUTICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)	01/06/20	AQ
Transcript : BioMarin Pharmaceutical Inc. - Shareholder/Analyst Call	27/05/20
BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines	13/05/20	GL
Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call	30/04/20
Transcript : Avery Dennison Corporation - Shareholder/Analyst Call	23/04/20
SABIN VACCINE INSTITUTE STRENGTHENS EBOLA SUDAN AND MARBURG VACCINES PROGRAM WITH ADDITIONAL NIAID PARTNERSHIP	05/03/20	GL
AVERY DENNISON CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	28/02/20	AQ
Avery Dennison : Announces Change in Board Leadership Structure	28/02/20	BU
Avery Dennison Corporation Announces Board Changes	28/02/20	CI
Alnylam Pharmaceuticals : SEC Filing - S-8	13/02/20	PU
“The Good Doctor,” “New Amsterdam,” “NCIS: New Orleans,” “The Peanut Butter Falcon” and Actor Nyle DiMarco Announced as Honorees for Annual Media Access Awards	05/11/19	GL
Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines	01/10/19	GL
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute	06/08/19	GL
Orbis : Secures USD $2 Million Funding from the David and Molly Pyott Foundation to Strengthen Eye Health in Zambia	20/06/19	PR
Transcript : Allergan plc Presents at Jefferies 2019 Healthcare Conference, Jun-06-2019 02:00 PM	06/06/19
Entertainment Industry Unites for Easterseals Disability Film Challenge Awards to Honor Filmmakers Who Inspire Change	13/05/19	GL
Finalists for the Easterseals Disability Film Challenge Announced and Showcased at the Newport Beach Film Festival	29/04/19	GL
Transcript : Alnylam Pharmaceuticals, Inc. - Shareholder/Analyst Call	25/04/19
Avery Dennison : Announces Transition in Board Leadership	01/03/19	BU
Transcript : Allergan plc Presents at 2018 Wells Fargo Securities Healthcare Conference, Sep-05-2018 09:05 AM	05/09/18
Sienna Biopharmaceuticals Appoints Finance Veteran, James M. Hindman, to Board of Directors	02/08/18	GL
ESSC Receives $1.75 Million Donation From David and Molly Pyott Foundation to Transform Former Santa Ana Corporate Offices Into Adult Day Services Center; Groundbreaking June 22nd	22/06/18	PR
Transcript : Evolus, Inc. Presents at Bank of America Merrill Lynch 2018 Healthcare Conference, May-17-2018 10:00 AM	17/05/18

No results for this search

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer